The Oncocept Thyroid Cancer Panel analyses SNVs, CNVs, Indels, and gene fusions using next-generation sequencing (NGS) technology.
Advanced Molecular Laboratory
Clinical specimen collection
SNVs, CNVs, Indels & Gene Fusions
Actionable molecular findings
The Oncocept Thyroid Cancer Panel detects clinically relevant DNA mutations and gene fusions associated with thyroid cancer, supporting diagnosis, prognosis and treatment selection.
Detects clinically important single nucleotide variants (SNVs), insertions/deletions (Indels) and copy number variations (CNVs).
Identifies clinically significant gene fusions and rearrangements involved in thyroid cancer.
The Oncocept Thyroid Cancer Panel supports molecular profiling across multiple thyroid cancer subtypes, helping clinicians with diagnosis, prognosis and treatment planning.
From sample collection to molecular reporting, the panel follows a streamlined next-generation sequencing (NGS) workflow to identify clinically relevant genetic alterations associated with thyroid cancer.
Appropriate clinical specimen is collected for molecular analysis.
High-quality DNA is extracted from the collected specimen.
Advanced NGS identifies SNVs, CNVs, Indels and Gene Fusions.
Molecular findings are reviewed and clinically interpreted by experienced experts.
Comprehensive molecular report delivered within 12 Working Days.
Support diagnosis, prognosis and treatment selection through a single test. Download the brochure or connect with our team to learn more.